SUKHVIR BENIPAL: Open Payments
NPI 1457194896 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 41 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 10 | $219 |
| Abbott Laboratories | 2 | $187 |
| Novo Nordisk Inc | 5 | $98 |
| Medtronic, Inc. | 3 | $88 |
| ABBVIE INC. | 4 | $72 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $38 |
| Antares Pharma, Inc. | 2 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
Products named: Korlym, FREESTYLE LIBRE 3, MINIMED 780G, Ozempic, Kerendia, GVOKE HYPOPEN, MOUNJARO, XYOSTED.
Industry payments across IN — which companies pay providers there.
